About Scolioscan
Scolioscan is a publicly listed company based in Hong Kong (China) founded in 2012. It operates as a radiation-free 3D ultrasound scoliosis assessment is developed. Scolioscan has raised $5.52 million across 2 funding rounds from investors including Fosun Pharmaceutical, PolyU and AEF Greater Bay Area Fund. Its chief executive is Margaret Han. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Screening Devices. Its competitors include EOS Iamging, OXOS Medical, Emerge Diagnostics, Aclarion and Knee Voice and 4 more; 6 of its 9 listed competitors have raised funding.
Company details
Scolioscan was founded in 2012 in Hong Kong, China, within the medical imaging sector. A radiation-free 3D ultrasound system for scoliosis evaluation is provided through the portable Scolioscan Air device. Cloud-based ScolioNet software is utilized for spinal image analysis. Operations focus on non-invasive diagnostics, serving healthcare providers in the region and beyond.
- Headquarters Hong Kong, China
- Stage Public
- SectorsHealthcare
- Website scolioscan.com
- Social LinkedIn X Facebook YouTube
- Total Equity Funding$5.52M (USD)
in 2 rounds
- Latest Funding Round$5.52M (USD), Seed
Mar 2024
- InvestorsFosun Pharmaceutical
& 2 more
Apps and channels of Scolioscan
its YouTube channel Aitrasound Medical Group has 21 subscribers and 8 videos.
Videos from Scolioscan
The most watched videos on Scolioscan's YouTube channel, Aitrasound Medical Group (21 subscribers). Click a video to play it here.
More on Aitrasound Medical Group.
Funding Insights of Scolioscan
Scolioscan has successfully raised a total of $5.52M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $5.52 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.52M
- Total Rounds 2
- Last Round Seed — $5.52M
- Investors Count 3
All 2 funding rounds of Scolioscan with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2024 | $5.52M | Seed | – | AEF Greater Bay Area Fund | – |
| Apr 2023 | – | Seed | – | – |
3 investors in total: 3 institutional.
Investors in Scolioscan
Scolioscan has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Fosun Pharmaceutical, PolyU and AEF Greater Bay Area Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | aefgreaterbayareafund.tcc.mode | - | |
Research, development, production, and sale of pharmaceuticals are provided. | 1994 | fosunpharma.com | Shanghai, China | |
Multiple courses and degrees are offered across diversified streams. | 1972 | polyu.edu.hk | Kowloon, China |
Investor details for Scolioscan
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Scolioscan
1 people are tracked at Scolioscan (1 in leadership).
| Name | Role | Group |
|---|---|---|
Margaret Han | CEO | Leadership |
Complete people profiles for Scolioscan
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Scolioscan
3 dated milestones of Scolioscan across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Scolioscan is founded.
- Funding First funding round.
- Funding Latest funding round, Seed, of $5.5M.
Competitors of Scolioscan
Scolioscan has 9 listed competitors in our database, 6 of them funded. They include EOS Iamging, OXOS Medical, Emerge Diagnostics, Aclarion and Knee Voice, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| eos-imaging.com | 1989 | Paris, France | $43.8M | – | 2D/3D orthopedic imaging systems and software solutions are developed. | |
| oxos.com | 2001 | Atlanta, United States | $42.46M | – | Orthopedic imaging devices and software are developed for surgical use. | |
| emergedx.com | 2012 | Carlsbad, United States | $6.74M | – | Soft tissue injuries are diagnosed via a specialized electrodiagnostic device. | |
| aclarion.com | 2008 | Broomfield, United States | $3.26M | 6 | SaaS-based radiology image analysis tools are provided for medical providers. | |
| kneevoice.com | 2015 | Santa Monica, United States | $1.87M | 7 | Knee health is monitored via a wearable device during activities. | |
| dsmedco.com | 2012 | Poway, United States | $11.52M | – | Acoustic coherent tomography imaging systems are provided for medical diagnostics. | |
| forethoughtmed.com | 2023 | China | – | – | Solutions for spinal health measurement and examination are provided. | |
| kneedly.se | 2021 | Gothenburg, Sweden | – | – | Knee ligament injuries are diagnosed by software for healthcare professionals. | |
| eos-imaging.us | 2018 | White Bear Lake, United States | – | – | Developer of orthopedic medical imaging systems |
Detailed competitors of Scolioscan
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Scolioscan
The website of Scolioscan (scolioscan.com) receives about 1.3K visits a month.
- Monthly visits1.3K
Top companies in Orthopedics
10 companies that operate in the same segment as Scolioscan (Orthopedics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Prosthetic and orthotic devices are developed for individuals with disabilities. | 1919 | Duderstadt, Lower Saxony, Germany | USD 17 M | USD 1.97 B | 4,125 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Developer of drugs for treating rare and autoimmune diseases | 2008 | Dublin, Ireland | USD 61.78 M | USD 617.41 M | – | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M | – | – | |
Robotic arms are provided for mobility and rehabilitation support. | 2004 | Boston, Massachusetts, United States | USD 17.21 M | USD 40.93 M | 185 | |
AI-powered drug discovery platform for various diseases | 2016 | New York, New York, United States | USD 608.25 M | – | 197 | |
Exoskeletons for medical rehabilitation and industrial productivity are provided. | 2005 | United States | USD 24.37 M | USD 71.6 M | 61 | |
Stabilization devices for healthcare are manufactured by the company. | 2005 | New York, New York, United States | USD 142.15 M | – | 43 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Scolioscan
Complete news archive for Scolioscan
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Scolioscan
Scolioscan was founded in 2012 and raised its 1st funding round 11 years after it was founded.
Scolioscan is headquartered in Hong Kong, China.
Margaret Han is the current CEO of Scolioscan.
Scolioscan is a funded company, having raised a total of $5.52M across 2 funding rounds to date.
Scolioscan was founded in 2012 in Hong Kong, China, within the medical imaging sector. A radiation-free 3D ultrasound system for scoliosis evaluation is provided through the portable Scolioscan Air device. Cloud-based ScolioNet software is utilized for spinal image analysis. Operations focus on non-invasive diagnostics, serving healthcare providers in the region and beyond.
Scolioscan's top competitors include EOS Iamging, OXOS Medical and Aclarion.
Scolioscan has 3 investors. Key investors include Fosun Pharmaceutical, PolyU, and AEF Greater Bay Area Fund.